Zobrazeno 31 - 40
of 85
pro vyhledávání: '"Pyrdol, Jason"'
Publikováno v:
Nature Immunology; May2005, Vol. 6 Issue 5, p490-496, 7p
Autor:
Reddy, Jayagopala, Illes, Zsolt, Xingmin Zhang, Encinas, Jeffrey, Pyrdol, Jason, Nicholson, Lindsay, Sobel, Raymond A., Wucherpfennig, Kai W., Kuchroo, Vijay K.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 10/26/2004, Vol. 101 Issue 43, p15434-15439, 6p
Publikováno v:
EMBO Journal; 6/16/2004, Vol. 23 Issue 12, p2348-2357, 10p
Autor:
Call, Matthew E.1,2, Pyrdol, Jason1, Wiedmann, Martin3, Wucherpfennig, Kai W.1,4 kai_wucherpfennig@dfci.harvard.edu
Publikováno v:
Cell. 12/27/2002, Vol. 111 Issue 7, p967. 13p.
Autor:
Krogsgaard, Michelle, Wucherpfennig, Kai W., Canella, Barbara, Hansen, Bjarke E., Svejgaard, Arne, Pyrdol, Jason, Ditzel, Henrik, Raine, Cedric, Engberg, Jan, Fugger, Lars
Publikováno v:
The Journal of Experimental Medicine; April 2000, Vol. 191 Issue: 8 p1395-1412, 18p
Publikováno v:
The Journal of Experimental Medicine; October 1998, Vol. 188 Issue: 8 p1511-1520, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moffett, Howell F, Cartwright, Adam N R, Kim, Hye-Jung, Godec, Jernej, Pyrdol, Jason, Äijö, Tarmo, Martinez, Gustavo J, Rao, Anjana, Lu, Jun, Golub, Todd R, Cantor, Harvey, Sharpe, Arlene H, Novina, Carl D, Wucherpfennig, Kai W
Publikováno v:
Nature Immunology; September 2017, Vol. 18 Issue: 10 p1173-1173, 1p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferrari de Andrade L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai_wucherpfennig@dfci.harvard.edu Lucas.FerrarideAndrade@mssm.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Kumar S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Ito Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Alves da Silva PH; Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Pan D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Pyrdol JW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts., Yoon CH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. kai_wucherpfennig@dfci.harvard.edu Lucas.FerrarideAndrade@mssm.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Jun; Vol. 8 (6), pp. 769-780. Date of Electronic Publication: 2020 Mar 24.